648 related articles for article (PubMed ID: 18079741)
1. The biology and future prospects of antivirulence therapies.
Cegelski L; Marshall GR; Eldridge GR; Hultgren SJ
Nat Rev Microbiol; 2008 Jan; 6(1):17-27. PubMed ID: 18079741
[TBL] [Abstract][Full Text] [Related]
2. Antivirulence compounds: a future direction to overcome antibiotic resistance?
Buroni S; Chiarelli LR
Future Microbiol; 2020 Mar; 15():299-301. PubMed ID: 32286100
[No Abstract] [Full Text] [Related]
3. Bacterial signaling as an antimicrobial target.
Ellermann M; Sperandio V
Curr Opin Microbiol; 2020 Oct; 57():78-86. PubMed ID: 32916624
[TBL] [Abstract][Full Text] [Related]
4. Quorum Sensing as Antivirulence Target in Cystic Fibrosis Pathogens.
Scoffone VC; Trespidi G; Chiarelli LR; Barbieri G; Buroni S
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013936
[TBL] [Abstract][Full Text] [Related]
5. Novel agents to inhibit microbial virulence and pathogenicity.
Escaich S
Expert Opin Ther Pat; 2010 Oct; 20(10):1401-18. PubMed ID: 20718591
[TBL] [Abstract][Full Text] [Related]
6. Anti-virulence Strategies to Target Bacterial Infections.
Mühlen S; Dersch P
Curr Top Microbiol Immunol; 2016; 398():147-183. PubMed ID: 26942418
[TBL] [Abstract][Full Text] [Related]
7. Fatty Acids as Antibiofilm and Antivirulence Agents.
Kumar P; Lee JH; Beyenal H; Lee J
Trends Microbiol; 2020 Sep; 28(9):753-768. PubMed ID: 32359781
[TBL] [Abstract][Full Text] [Related]
8. Quenching the quorum sensing system: potential antibacterial drug targets.
Kalia VC; Purohit HJ
Crit Rev Microbiol; 2011 May; 37(2):121-40. PubMed ID: 21271798
[TBL] [Abstract][Full Text] [Related]
9. The art of antibacterial warfare: Deception through interference with quorum sensing-mediated communication.
Rampioni G; Leoni L; Williams P
Bioorg Chem; 2014 Aug; 55():60-8. PubMed ID: 24823895
[TBL] [Abstract][Full Text] [Related]
10. Global priority pathogens: virulence, antimicrobial resistance and prospective treatment options.
M Campos JC; Antunes LC; Ferreira RB
Future Microbiol; 2020 May; 15():649-677. PubMed ID: 32495702
[No Abstract] [Full Text] [Related]
11. Quorum-Sensing Systems as Targets for Antivirulence Therapy.
Defoirdt T
Trends Microbiol; 2018 Apr; 26(4):313-328. PubMed ID: 29132819
[TBL] [Abstract][Full Text] [Related]
12. [Target-specific screening of antivirulence preparations for chronic infection therapy].
Zigangirova NA; Gintsburg AL
Zh Mikrobiol Epidemiol Immunobiol; 2011; (4):107-15. PubMed ID: 21913401
[TBL] [Abstract][Full Text] [Related]
13. Targeting virulence not viability in the search for future antibacterials.
Heras B; Scanlon MJ; Martin JL
Br J Clin Pharmacol; 2015 Feb; 79(2):208-15. PubMed ID: 24552512
[TBL] [Abstract][Full Text] [Related]
14. Approaches to the Structure-Based Design of Antivirulence Drugs: Therapeutics for the Post-Antibiotic Era.
Neville N; Jia Z
Molecules; 2019 Jan; 24(3):. PubMed ID: 30678155
[TBL] [Abstract][Full Text] [Related]
15. Parallels among natural and synthetically modified quorum-quenching strategies as convoy to future therapy.
Gupta K; Daroch P; Harjai K; Chhibber S
Microbiology (Reading); 2019 Dec; 165(12):1265-1281. PubMed ID: 31264956
[TBL] [Abstract][Full Text] [Related]
16. Quorum Sensing Inhibition by Marine Bacteria.
Borges A; Simões M
Mar Drugs; 2019 Jul; 17(7):. PubMed ID: 31340463
[TBL] [Abstract][Full Text] [Related]
17. Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance.
Dickey SW; Cheung GYC; Otto M
Nat Rev Drug Discov; 2017 Jul; 16(7):457-471. PubMed ID: 28337021
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances in Anti-virulence Therapeutic Strategies With a Focus on Dismantling Bacterial Membrane Microdomains, Toxin Neutralization, Quorum-Sensing Interference and Biofilm Inhibition.
Fleitas Martínez O; Cardoso MH; Ribeiro SM; Franco OL
Front Cell Infect Microbiol; 2019; 9():74. PubMed ID: 31001485
[TBL] [Abstract][Full Text] [Related]
19. Small molecules modulating AHL-based quorum sensing to attenuate bacteria virulence and biofilms as promising antimicrobial drugs.
Wang Y; Ma S
Curr Med Chem; 2014; 21(3):296-311. PubMed ID: 24164200
[TBL] [Abstract][Full Text] [Related]
20. Quorum quenching agents: resources for antivirulence therapy.
Tang K; Zhang XH
Mar Drugs; 2014 May; 12(6):3245-82. PubMed ID: 24886865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
